1.Balch, A. and Mackin, A. 2007. Canine immune- mediated hemolytic anemia: pathophiosology, clinical sign, and diagnosis. Compend. Cont. Educ. Vet., 29(4): 217-225.

2.Brunton, L.L., Lazo, S.J. and Parker, K.L. 2005. In: Goodman and Gilman’s The Pharmacological basis of therapeutics. (11th Ed.). McGraw-hill, New York, pp. 201.

3.Day, M.J. 1996. Inheritance of serum autoantibody, reduced serum IgA and autoimmune disease in a canine breeding colony. Vet. Immunol. Immunopathol., 53(3–4): 207–219.

4.Dowling, P.M. 1995. Immunosuppressive drug therapy. Can. Vet. J., 36(12): 781-783.

5.Fenty, R.K., DeLaforcade, A.M. Shaw, S.P. and O’Toole, T.E. 2011. Identification of hypercoagulability in dogs with primary immune-mediated hemolytic anemia by means of thromboelastography. J. Am. Vet. Med. Assoc., 238: 463–467.

6.Hodges, J. and Christopher, M.M. 2011. Diagnostic efficacy of using erythrocyte indices and polychromasia to identify regenerative anemia in dogs. J. Am. Vet. Med. Assoc., 238: 1452-1458.

7.Houston, D.M. and Taylor, J.A. 1991. Acute pancreatitis and bone marrow suppression in a dog given azathioprine. Can. Vet. J., 32: 496-497.

8.Ishihara, M., Fujino, Y., Setoguchi, A., Takahashi, M., Nakashima, K., Ohno, K. and Tsujimoto, H. 2010. Evaluation of prognostic factors and establishment of a prognostic scoring system for canine primary immune-mediated hemolytic anemia. J. Vet. Med. Sci., 72(4): 465–470.

9.Jutkowitz, A., Kinns, J., Habing, A., Beal, M. 2013. CT angiography for detection of pulmonary thromboembolism and portal vein thrombosis in dogs with immune-mediated hemolytic anemia (IMHA). J. Vet. Emerg. Crit. Care., 23(S1): S15.

10.Kaneko, J.J., Harvey, J.W. and Bruss, M.L. 2008. In: Clinical biochemistry of domestic animals. (6th Ed.). Elsevier, pp. 904.

11.Kledmanee, K., Suwanpakdee, S., Krajangwong, S., Chatsiriwech, J., Sukasai, P., Suwannachat, P., Sariya, L., Buddhirongawatr, R., Charoonrut, P. and Chaichoun, K. 2009. Development of multiplex polymerase chain reaction for detection of Ehrlichia canis, Babesia spp. and Hepatazoan canis in canine blood. Southeast Asian T. Med. Public Health., 40(1): 35–39.

12.Kucinskiene, G., Schuberth, H.J., Leibold, W.J. and Pieskus, J. 2005. Flow cytometric evaluation of bound IgG on erythrocytes of anaemic dogs. Vet. J., 169: 303–307.

13.Mason, N., Duval, D., Shofer, F.S. and Giger, U. 2003. Cyclophosphamide exerts no beneficial effect over prednisone alone in the initial treatment of acute immune mediated hemolytic anemia in dogs: a randomized controlled clinical trial. J. Vet. Intern. Med., 17(2): 206–212.

14.McCullough, S. 2003. Immune-mediated hemolytic anemia: understanding the nemesis. Vet. Clin. North. Am. Small Anim. Pract., 33: 1295–1315.

15.Mitchell, K. and Kruth, S. 2010. Immune-mediated hemolytic anemia and other regenerative anemias. In: Textbook of Veterinary Internal Medicine. 7th edn. Eds S. J. Ettinger and E.C. Feldman, Saunders Elsevier, St. Louis, MO, USA. pp 761-772.

16.Morley, P., Mathes, M., Guth, A. and Dow, S. 2008. Antierythrocytes antibodies and disease associations in anemic and nonanemic dogs. J. Vet. Intern. Med., 22: 886–892.

17.Piek, C.J., Van Spil, W.E., Junius, G. and Dekker, A. 2011. Lack of evidence of a beneficial effect of azathioprine in dogs treated with prednisolone for idiopathic immune-mediated haemolytic anaemia: a retrospective cohort study. BMC Vet. Res., 7: 15.

18.Piek, C.J., Van Spil, W.E., Junius, G. and Dekker, A. 2011. Lack of evidence of a beneficial effect of azathioprine in dogs treated with prednisolone for idiopathic immune-mediated haemolytic anaemia: a retrospective cohort study. BMC Vet. Res., 7: 15.

19.Rajagopal, A.S., Abdul Basith, S., Gomathinayagam, S. and Dhinakarraj, G. 2009. Evaluation of PCR and IFAT in the Diagnosis of Canine Ehrlichiosis. J. App. Anim. Res., 35(2): 189–91.

20.Rang, H.P., M.M. Ritter, J.M. and Flower, R.J. 2007. In: Rang and Dales Pharmacology. (6th Ed.). Edinburgh, Churchill Livingstone, pp. 844.

21.Rinkardt, N.E. and Kruth, S.A. 1996. Azathioprine-induced bone marrow toxicity in four dogs. Can. Vet. J., 37: 612-613.

22.Scott-Moncrieff, J.C., Treadwell, N.G. and McCullough, S.M. 2001. Hemostatic abnormalities in dogs with primary immune-mediated hemolytic anemia. J. Am. Anim. Hosp. Assoc., 37: 220-227.

23.Swann, J.W. and Skelly, B.J. 2013. Systemic review of evidence relating to treatment of Immune Mediated Hemolytic anemia in dogs. J. Vet. Intern. Med., 27: 1-19.

24.Wang, A., Smith, J.R. and Creevy, K.E. 2013. Treatment of canine idiopathic immune mediated haemolytic anaemia with mycophenolate mofetil and glucocorticoids: 30 cases (2007 to 2011). J. Small. Anim. Pract., 54(8): 399–404.

25.Weinkle, T.K., Center, S.A., Randolph, J.F., Warner, K.L., Barr, S.C. and Erb, H.N. 2005. Evaluation of prognostic factors, survival rates, and treatment protocols for immune-mediated hemolytic anemia in dogs: 151 cases (1993-2002). J. Am. Vet. Med. Assoc., 226: 1869-1880.

26.Whelan, M.F., Toole, T.E.O., Chan, D.L., Rosanski, E.A., Armelle, M.A. Crawford, S.L. and Cotter, S.M. 2009. Use of immunoglobulin in addition to glucocorticoids for the initial treatment of dogs with immune-mediated hemolytic anemia. J. Vet. Emerg. Care. 19: 158-164.

27.Whitley, N.T. and Day, M.J. 2011. Immunomodulatory drugs and their application to the management of canine immunemediated disease. J. Small. Anim. Pract., 52(2): 70–85.